- Paul Workman is chief executive of Institute of Cancer Research in London
- Says despite huge advances in understanding cancer, drugs are still lacking
- Argues finance is the problem, with companies putting profits first
- Should be given incentives to develop treatments for rarer cancers
Ben Spencer, Science Reporter for the Daily Mail
144
View
comments
Professor Paul Workman, chief executive of the Institute of Cancer Research in London, warned today the war against cancer has lost momentum
The system for researching new cancer treatments is ‘broken’, one of Britain’s top academics has claimed.
Professor Paul Workman, chief executive of the Institute of Cancer Research in London, accused ‘risk averse’ pharmaceutical firms of only developing drugs they know will turn a profit.
Speaking at the World Oncology Forum in Switzerland, the professor said the war against cancer has lost momentum, despite huge theoretical advances in the laboratory.
‘There have been some impressive advances in the personalised treatment of cancer,’ Professor Workman said.
‘But overall progress has failed to keep pace with the dramatic advances over the last 20 years in our knowledge about cancer biology and genetics.
‘We could, and should, be doing much better.
‘It is my contention that the whole model of cancer drug discovery – in which private companies and academia should be working together to take the most exciting, innovative new drugs to patients – is broken and in need of help.’
Professor Workman, 62, whose own career has focused on the search for cancer treatments, said pharmaceutical giants were only interested in ‘the low hanging fruits’ of cancer which are easily treatable.
He claimed theoretical scientists have identified 500 cancer-related proteins which could be attacked by drugs – but only 5 per cent of these treatments have so far been developed.
A major problem, he admitted, is finance.
Clinical trials are hugely expensive, he said, so companies are unwilling to invest in ‘risky’ drugs which might not be successful.
‘The key to driving faster progress in cancer treatment is incentivising private companies, and the academic organisations that work with them, to take the risks they need to take to discover the truly innovative treatments of the future.
-
Mother loses 9st after being refused surgery on crippling…
Keep slim by going out in the sun: Exposure to UV rays…
Britain should become a ‘smoke-free’ country within five…
One in six deaths is due to lack of exercise: Now Britain is…
‘In return, pharmaceutical companies will need to accept that they are receiving help from governments, regulators and health services, and they can’t expect to set prices that squeeze every penny of possible profit from those same public institutions.’
He called for the Government to intervene to make things easier for the big drugs companies.
He suggested tax breaks for companies which invest in treatments for rare and childhood cancers, where it is less profitable to develop drugs.
He also called for a quicker and simpler drugs authorisation system, tax credits for research and development and stronger patents so companies can see a return from their investments.
He explained that overall progress has failed to keep pace with the dramatic advances over the last 20 years in understanding the diseaseÂ
But he also called on universities and drugs firms to change the way they do clinical trials to bring down the cost.
More targeted and smaller clinical trials will reduce the initial outlay, and sharing the cost and risk of trials between universities and companies could benefit all parties, he said.
‘I see our broken model of drug discovery and development as the biggest challenge in our efforts to get exciting and game-changing new drugs to patients,’ he said
‘Until we fix it, we will not see the number of really innovative treatments – capable of making a big impact on the lives of patients – that we should be expecting.’
The Government said it had already introduced 10 per cent tax relief on research and development expenditure and a further tax breaks for patented inventions and innovations.
George Freeman, Minister for Life Sciences, said: ‘We want to make Britain the best place in the world to design and deliver innovative 21st-century medicines, and to accelerate and support the increasing “stratification†of medicines which cancer has spearheaded.
‘That’s why we are investing £1 billion annually in the National Institute for Health Research NHS infrastructure, launched and committed to expand the early access to medicines scheme, ring-fenced £750 million for cancer research and development over four years and committed an extra £160 million to the cancer drugs fund.’
Â
or comment on this article
-
Horrifying video shows locals indifference to severed heads
-
Washington High School shooter Jaylen Fryberg chanting
-
Fox News host tells young women: don’t vote, go back to…
-
Russell Brand’s explosive rant on BBC’s Newsnight
-
San Franciscan tour guide’s explosive racist tirade on…
-
Student opens fire at a Washington state high school
-
The moment airstrikes obliterate black flag of ISIS
-
Russian grave-robber who dug up the graves of 150 little…
-
Kyle reveals his baby on Christey Knows Best (archive)
-
Ace peanut seller makes amazing multi-tier transaction
-
NYPD bin protective wear after leaving ebola danger zone
-
Secret Service dogs who took down White House fence-jumper
-
Hero teacher ‘stopped massacre’: She grabbed homecoming…
-
EXCLUSIVE – ‘He’s a snake who shut me out of my child’s…
-
EXCLUSIVE – ‘I’m angry he’s getting trashed!’ Family leap to…
-
Numb to horror: Women walk past headless corpses in the…
-
Open for business! New York eateries visited by Ebola doctor…
-
Nurse returning from Africa to New Jersey is rushed to…
-
Fifteen-year-old gunman pictured as a smiling homecoming…
-
Oklahoma lake reveals its secrets after 40 years: Car wrecks…
-
Domestic abuse victim whose drunk boyfriend was beating her…
-
Out of danger and straight into the arms of the President:…
-
Pictured: The abandoned property where the body of missing…
-
Rosie O’Donnell comes under fire after defending model…
Comments (144)
what you think
-
Newest -
Oldest -
Best rated -
Worst rated
The comments below have not been moderated.
The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.
Find out now